| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A randomized phase II trial of cisplatin plus gemcitabine versus carboplatin plus gemcitabine in patients with completely resected non-small cell lung cancer: Hokkaido Lung Cancer Clinical Study Group Trial (HOT0703)
|
Fukumoto, Shin-ichi
|
|
|
86 |
1 |
p. 117-127
|
artikel
|
| 2 |
Assessment of effects of repeated oral doses of fedratinib on inhibition of cytochrome P450 activities in patients with solid tumors using a cocktail approach
|
Ogasawara, Ken
|
|
|
86 |
1 |
p. 87-95
|
artikel
|
| 3 |
Berberine chloride suppresses non-small cell lung cancer by deregulating Sin3A/TOP2B pathway in vitro and in vivo
|
Chen, Jian
|
|
|
86 |
1 |
p. 151-161
|
artikel
|
| 4 |
Comparison between single-agent and combination chemotherapy as second-line treatment for advanced non-small cell lung cancer: a multi-institutional retrospective analysis
|
Yi, Yanjiao
|
|
|
86 |
1 |
p. 65-74
|
artikel
|
| 5 |
Correction to: Exposure-survival analyses of pazopanib in renal cell carcinoma and soft tissue sarcoma patients: opportunities for dose optimization
|
Verheijen, R. B.
|
|
|
86 |
1 |
p. 163
|
artikel
|
| 6 |
C-reactive protein at 1 month after treatment of nivolumab as a predictive marker of efficacy in advanced renal cell carcinoma
|
Noguchi, Go
|
|
|
86 |
1 |
p. 75-85
|
artikel
|
| 7 |
Effect of food on the pharmacokinetics of the WEE1 inhibitor adavosertib (AZD1775) in patients with advanced solid tumors
|
Någård, Mats
|
|
|
86 |
1 |
p. 97-108
|
artikel
|
| 8 |
First evidence for the antitumor activity of nanoliposomal irinotecan with 5-fluorouracil and folinic acid in metastatic biliary tract cancer
|
Taghizadeh, Hossein
|
|
|
86 |
1 |
p. 109-115
|
artikel
|
| 9 |
Influences of preoperative metformin on immunological factors in early breast cancer
|
Tsukioki, Takahiro
|
|
|
86 |
1 |
p. 55-63
|
artikel
|
| 10 |
New DPYD variants causing DPD deficiency in patients treated with fluoropyrimidine
|
García-González, Xandra
|
|
|
86 |
1 |
p. 45-54
|
artikel
|
| 11 |
Pharmacokinetics of tablet and liquid formulations of oral 6-mercaptopurine in children with acute lymphoblastic leukemia
|
Larsen, Rikke Hebo
|
|
|
86 |
1 |
p. 25-32
|
artikel
|
| 12 |
Reactive oxygen species in cancer: a paradox between pro- and anti-tumour activities
|
Kohan, Romina
|
|
|
86 |
1 |
p. 1-13
|
artikel
|
| 13 |
Sorafenib exposure and its correlation with response and safety in advanced hepatocellular carcinoma: results from an observational retrospective study
|
Noda, Satoshi
|
|
|
86 |
1 |
p. 129-139
|
artikel
|
| 14 |
Validation of an online tool for early prediction of the failure-risk in gestational trophoblastic neoplasia patients treated with methotrexate
|
Dekeister, Kathleen
|
|
|
86 |
1 |
p. 15-24
|
artikel
|
| 15 |
Wide variation in tissue, systemic, and drain fluid exposure after oxaliplatin-based HIPEC: results of the GUTOX study
|
de Jong, Loek A. W.
|
|
|
86 |
1 |
p. 141-150
|
artikel
|
| 16 |
YLZ-F5, a novel polo-like kinase 4 inhibitor, inhibits human ovarian cancer cell growth by inducing apoptosis and mitotic defects
|
Zhu, Yongxia
|
|
|
86 |
1 |
p. 33-43
|
artikel
|
Tijdschrift beschrijving